LECTURE - Resistance to Antimicrobials Flashcards
5 main mechanisms by which bacteria become resistant to antibiotics
- limiting access of antibiotic to organism
- enzymatic inactivation of the antibiotic
- active efflux of antibiotic from bacterial cell
- modification or protection of antibiotic target
- failure to activate antibiotic
how do organisms limit access of antibiotics to its target?
GRAM NEG :
- some (like vancomycin) are too big to get through porin channels
- single mutations in porins can alter their channels = more resistant
GRAM POS:
- thicker cell wall in some vancomycin-intermediate resistant S. aureus ‘mop up’ vancomycin making it less available to proper targets
Reduced uptake at the cytoplasmic membrane
- not common
- for ex: aminoglycoside antibiotics use a transporter in the bacterial cytoplasmic membrane to enter the cell; alteration of this transporter could prevent entry of the aminoglycoside (possibly during growth in anaerobic conditions)
gram neg with beta lactamase
get more “bang for their buck” bc enzyme is concentrated in periplasmic space
gram positives beta lactamase
they excrete beta-lactamase into their extracellular environment where they get diluted
how can we prevail against beta lactamases?
- by adding clavulanic acid or sulbactam (B-lactam analogs that inactivate bacterial enzymes)
- BUT increased production of beta-lactamase by a bacterium can tip the scales in bacterium’s favour again
aminoglycosides inactivation
- when organisms covalently attach acetyl, phosphoryl, or adenyl groups
“-rylation..”
other examples of enzymatic inactivation of the antibiotic
- streptogramin acetyltransferase (vat and sat genes) found in staph and enterococci
- possible role for tetX gene in oxidative inactivation of tetracycline
one of the most common mechanisms of resistance
active efflux of the antibiotic
- ATP is used by a cytoplasmic pump to expel the antibiotic
five classes of efflux pumps
- MATE: multi-drug and toxic compound extrusion
- MFS: major facilitator superfamily
- SMR: staphylococcal multi-resistance
- RND: resistance modulation division
- ABC: ATP binding cassette
how do organisms modify/protect antibiotic targets in B lactams
- alternative PBP (transpeptidase enzyme) that doesn’t bind penicillin; no binding = no effect on peptidoglycan synthesis; organisms grow normally
- big problem in gram pos like mecA gene in Staph aureus encoding PBP2’
resistance to macrolides, lincosamides, ketolides, etc, by modification or protection of antibiotic target
- rRNA methylase: enzymes encoded by ermA, B, F, and G = can covalently add a methyl group to a specific adenine residue on the 23S rRNA = rendering the 50S subunit immune to these five antibiotic types
- known as MLSKO(B) group = common in Bacteroides species and some gram pos cocci
resistance to quinolone and rifampin via modification or protection of target
mutation in DNA gyrase B subunit or RNA polymerase, respectively, renders the enzymes immune to binding by the antibiotics
resistance to trimethoprim and sulfonamides via modification or protection of target
mutation in enzymes of the folic acid pathway that are affected by these antibiotics = allows enzymes to still do wok but have a lower affinity for antibiotic than for their intended substrate
resistance to metronidazole
- mutation in expression levels of flavodoxin = fail to convert metronidazole into its active form so it has no effect on the bacterium
- Isoniazid for treating TB also has to be activated, by a mycobacterial catalase, and mutation in catalase can cause resistance
ways resistance genes are acquired by bacteria: (5)
- mutation
- plasmids
- transposons
- integrons
- conjugative transposons